Document is current

Any future updates will be listed below

Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes

Crossref DOI link: https://doi.org/10.1186/s13075-023-03005-x

Published Online: 2023-02-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark